Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model

Diseases of the Colon and Rectum

Volumn 40, Issue 3, 1997, Pages 317-321

  Akhter, Javed ^a   Chen, Xianghai ^a   Bowrey, Patricia ^a   Bolton, Elaine J ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colon carcinoma; Proliferation; Vitamin D; Vitamin D3 analogs

Indexed keywords

COLECALCIFEROL DERIVATIVE; SEOCALCITOL; ANTINEOPLASTIC AGENT; CALCITRIOL; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; WEIGHT REDUCTION; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL STRAIN CACO 2; DISEASE MODEL; MITOSIS INDEX;

ANIMALS; ANTINEOPLASTIC AGENTS; CACO-2 CELLS; CALCITRIOL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOTIC INDEX; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030610419     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02050422     Document Type: Article

References (19)

1. 3. Proc Natl Acad Sci U S A 1981; 76:4990-4.
2. 3 on human cancer cells in vitro. J Steriod Biochem 1987;27:825-8.
3. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer proliferation. Lancet 1989;1:188-91.
4. 3 metabolites. Cancer Res 1983;43:4443-7.
5. 3 receptor: gene regulation and genetic circuitry. FASEB J 1988;2:3043-53.
6. 3. Cancer Res 1987;47:21-5.
7. 3 analogs and their potential for inhibiting cancer cell growth. Drugs Future 1993;18-.1057-61.
8. Colston KW, Mackay AG, James SY, Binderup I, Chander S, Coombes RC. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 1992;44: 2273-80.
9. 3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells. Br J Surg 1996;83:229-30.
10. Euhus D, Hudd C, La Regina M, Johnson F. Tumor measurement in nude mouse. J Surg Oncol 1986;31: 229-34.
11. Stewart GJ, Connor JL, Lawson JA, Preketes A, King J, Morris DL. Octreotide reduces the kinetic index, proliferating cell nuclear antigen-maximum proliferative index, in patients with colorectal cancer. Cancer 1995;76: 572-8.
12. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 1991;129:832-7.
13. 3 and prostate cancer cell proliferation in vivo. Urology 1995; 46:365-9.
14. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993; 53:3712-8.
15. 3 receptors and human colon adenocarcinoma. Br J Surg 1991;78:435-9.
16. 3 receptors in established human cancer cell lines in culture. Cancer Res 1982;42: 1116-9.
17. 3 receptors in normal and malignant human colorectal tissues. Cancer Lett 1994; 86:67-73.
18. 3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res 1987;7:817-22.
19. 3 on cell cycle kinetics of T47D human breast cancer cells. J Cell Physiol 1989;138: 611-6.